Diabetes Conference 2020
Euroscicon is proud to announce "4th World Congress on Diabetes and Obesity" to be held in Dublin, Ireland during May 25-26, 2020 with the overall theme Recent advances in Diabetes and Obesity
After the successful conduct of “3rd World Congress on Diabetes and Obesity” in Rome, Italy during 18-19 March, 2019. We take the immense pleasure to announce the next edition of our congress.
Diabetes conferences are conducted all over the world every year in distinct number to support the immense number of researches going on in the field of Diabetes and endocrinology. Majority of the Diabetes conferences are conducted every year with the motive to organize researchers from different parts of the world to share their knowledge and jointly form new solutions to carry out for proficient and productive researches as diabetes is one of the major threats to our society with millions of new cases are recorded every year .
Benefits of Participation:
Who can attend?
Diabetes Conference 2020
Opportunities for Conference Attendees
Specialists & Educators:
Students & Research Scholars:
Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Book Launch event
Universities, Associations & Societies:
Exhibitor and Vendor booths
Marketing and Networking with clients
Beneficial effects of breastfeeding in women with gestational diabetes mellitus.
Clogging the mitochondrial protein-entry gate promotes obesity.
Reduced carbohydrate intake improves type 2 diabetics' ability to regulate blood sugar.
Sessions and Tracks
Obesity increases the chances of developing type 2 diabetes. In such case although the production of insulin is enough in amount but the cells in our body becomes resistant to insulin and stops the entry of insulin into the cell. Being overweight stresses the insides of individual cells. Specifically, too much of eating stresses the membranous network inside cells known as endoplasmic reticulum (ER). once the ER has a lot more nutrients to process than it can handle, it sends out alarm signal telling the cell to dampen down the hypoglycemic agent receptors on the cell surface. This interprets to hypoglycemic agent resistance and to persistently high concentrations of the sugar aldohexose within the blood. This is one of the confirming signs of diabetes.
The human body secretes hormones to maintain the chemical balance in the body in order to run our body smoothly. These hormones are released in our body by some glands that are considered to be the part of the endocrine system. The major endocrine organs present in our body include pituitary gland, thyroid gland, adrenalin gland, ovaries, testes and pancreas.In diabetes patients the main problem that incurs due to the endocrine system is the hormone imbalance. This is because of the lack or excessive secretion of the hormone from their respective gland. But diabetes is majorly a pancreatic disorder that is incurred due to irregular release of Insulin
Endocrinology is the study of the endocrine system in the body. This is a system of glands which secrete hormones .Humans have over 50 different hormones. They exist in small amounts and still have a significant impact on bodily function and development. Hormones regulate metabolism, respiration, growth, reproduction, sensory perception and movement. Hormone imbalances are the underlying reason for a wide range of medical conditions. Endocrinology focuses on both the hormones and the glands and tissues that produce them.
The metabolism of people with diabetes is almost identical to the metabolism of people without diabetes. The only difference is the volume or effectiveness of the insulin produced by the body. In type 2 diabetes, the effectiveness of insulin is reduced and in type 1 diabetes, insulin levels in the body are very low but the proper functioning of metabolism is reliant on the delivery of insulin. This can be done with introduction of external insulin to the body with the help of injection or pump.
The pancreas is academic degree organ placed behind the lower a vicinity of the abdomen, above the spine and plays a really a vital role in diabetes. The pancreas is that the organ that produces the insulin, one the foremost hormones that helps to manage hexose or the blood sugar glucose levels by aiding the transport of aldohexose from the blood into neighboring cells. The cells that manufacture the insulin are known as beta cells.
Endocrine disorders can be classified according to the intensity of hormonal activity and according to the origin of endocrine disorder. From the intensity of hormonal activity of endocrine gland we can distinguish hyper function of endocrine gland, which is characterized by increased secretion of its hormone as well as by increased concentration of this hormone in circulating blood.
- Clinical Researches in Diabetes (Trials and Case studies)
Clinical researches / clinical trials are approaches to precisely test medication or gadget in patients before it is endorsed by the FDA to be utilized in public. Clinical trials are an important and critical step in our having the capacity to have new medications for diabetes and other varied conditions. A case study is a methodology and a strategy that investigates a phenomenon with its real-life context. Case studies and clinical trials are used to develop or assess the quality of the medications being developed.
Cardiovascular diseases affects the circulation of blood and poor circulation leads to complications. Diabetes increases the risk of heart diseases and stroke. Reports states, most of the people with diabetes, particularly type 2 diabetes are having high blood pressure. These complications embrace coronary cardiopathy (CHD), stroke, peripheral blood vessel malady, renal disorder, retinopathy, and probably pathology. Attributable to the aging of the population and an increasing prevalence of obesity and inactive life habits within the prevalence of diabetes is increasing. 68% of people age 65 or older with diabetes die from some of the heart diseases and 16% die of stroke. Adults with diabetes are two to four times more likely to die from heart disease than adults without diabetes.
Nanotechnology holds a great deal of promise for the world of medicine. It is likely that some of the first truly revolutionary changes noticeable in our everyday lives will be brought about by Nano-medicine. the possibilities of Nano-medicine include Nano formulations for efficient drug delivery, smart drugs which only activate when needed, engineered microbes which produce human hormones.
Diabetic nephropathy (DN), also known as diabetic kidney disease, is the chronic loss of kidney function occurring in those with diabetes mellitus. Protein loss in the urine due to damage to the glomeruli may become massive, and cause a low serum albumin with resulting generalized body swelling (edema) and result in the nephrotic syndrome. Likewise, the estimated glomerular filtration rate (eGFR) may progressively fall from a normal of over 90 ml/min/1.73m2 to less than 15, at which point the patient is said to have end-stage kidney disease (ESKD). It usually is slowly progressive over years.
Bariatric surgical procedures cause weight loss by restricting the amount of food the stomach can hold, causing malabsorption of nutrients, or by a combination of both gastric restriction and malabsorption. Bariatric procedures also often cause hormonal changes. Most weight loss surgeries today are performed using minimally invasive techniques (laparoscopic surgery). The basic principle of bariatric surgery is to restrict food intake and decrease the absorption of food in the stomach and intestines.
Pediatric or juvenile diabetes is chronic type 1 diabetes which affects the young population, particularly children under the age of 15. Such diabetes brings about lifetime dependency on exogenous insulin. Signs and symptoms of pediatric diabetes are like other types of diabetes and children are more likely to develop the disease if there is a family history of diabetes. Complications of pediatric diabetes also generally include heart diseases, nerve damage, nerve, kidney and eye damage, skin conditions, osteoporosis, etc. Proper diagnosis, treatment and management are the possible remedies for this type of diabetes.
Pediatric Endocrinology is a subspecialty of pediatrics dealing with metabolic and endocrine disorders in children. The most common disease of the speciality is type 1 diabetes , which usually accounts for at least 50% of a typical clinical practice. The next most common problem is growth disorders , especially those amenable to growth hormone treatment. Pediatric endocrinologists are usually the primary physicians involved in the medical care of infants and children with intersex disorders. It also deals with hypoglycaemia and other forms of hyperglycemia in childhood, variations of puberty as well other adrenal, thyroid and pituitary problems.
Diabetes became a serious and deadly disease mainly because of obesity and poor lifestyle. Although diabetes can be prevented, treated, controlled, and the risk lessened via various health and lifestyle interventions like physiotherapy. Physiotherapy can be used wisely to diagnosis, treat, and manage musculoskeletal (MSK) manifestations and complications of type 2 diabetes. Physiotherapy mehods like effective exercise, physical conditioning, and active, healthy living can be effective in treating diabetes
In most cases of stem cell therapy, using one's own stem cells is more more helpful for the exocrine gland to regenerate and boost its ability to produce insulin. Procedure continues to achieve success, with patients experiencing health advantages even six months after stem cell diabetes treatment. Repeated applications of adipose stem cells is one of the most effective treatment for type two diabetes, providing an open window to create dietary changes, supplementation and exercise much more effective for long-term management of blood glucose.
Diabetic retinopathy is a condition or disease of eye that is found in patients with Diabetes. This can be once high blood glucose levels cause injury to blood vessels within the membrane. These blood vessels will swell and leak. Or they'll shut, stopping blood from passing through. generally abnormal new blood vessels grow on the membrane. All of those changes will steal your vision.
Obesity not only increases the cardiovascular risks but it damages more than just the heart and blood system. It is also the major cause of bile stones, osteoarthritis and respiratory problems. Obesity closely interferes with many health conditions that underlie cardiovascular disease, including high blood pressure, diabetes and abnormal blood cholesterol. Additionally, weight gain is a frequent consequence of a heart-damaging lifestyle such as lack of exercise and a fat diet. Obesity can also lead to Cardiac arrest. This is a serious condition when the heart is unable to pump enough amount of blood to satisfy the body’s requirement.
Obesity is directly or indirectly linked to some endocrine diseases, including basic ones such as hypothyroidism and polycystic ovarian syndrome to rare ones such as Cushing's syndrome, central hypothyroidism, and hypothalamic disorders. Mechanisms to upgrade weight shift in as per endocrine condition. Hypothyroidism is related to the combination of hyaluronic acid in different tissues, extra liquid preservation due to reduced cardiovascular yield and reduced thermogenesis. The net abundance of androgen gives the impression of being urgent in the progression of central obesity. In Cushing's syndrome, association with thyroid and developmental hormones plays a significant part in increasing adipocyte separation and adipogenesis. This audit also depicts remaining rare cases: hypothalamic obesity due to central hypothyroidism and combined hormone deficiencies.
Diabetes and cancer are two of the biggest threats with tremendous impact to humans during this decade. However scientists are yet to prove a relation between the two. Recent studies show some evidences however not definite proofs that some diabetes treatment methods increases the danger of cancer. Instances from the recent studies includes anti-diabetics, the foremost usually used anti-diabetic drug, appears to lower cancer risk. however there is conjointly proof from some studies conducted by others that hypoglycemic agent, notably long hypoglycemic agent glargine (Lantus), could increase cancer risk.
Researches states that both type 1 and type 2 diabetes are on the rise among young adults. Current estimates suggest that up to 3 million youth and adults in the United States are living with type 1 diabetes . A report on Diabetes in Youth found that newly diagnosed cases of Type 2 diabetes in children and teens increased by about 4.8 percent in each year of the study’s period between 2002 and 2012.
The short term occurrence of diabetes in pregnant ladies is majorly known as Gestational diabetes. It is seen in non- diabetic mothers suddenly develops diabetes during pregnancy and the symptoms disappears after the baby’s birth.
The damage caused to nerves by diabetes is called Diabetic neuropathy. The main cause of this damage is the pressure generated due to high blood glucose levels in the blood for a very long time and high levels of fats, such as triglycerides in the blood. Symptoms vary with the type of diabetic neuropathy.Mainly diabetic neuropathy is divided into 4 types namely;
Dementia being called the disorder due to a result of trauma or brain illness can be connected to diabetes mellitus as mentioned in some of the studies. Although not much is known about the connection between dementia and diabetes mellitus. Dementia is the term used to specify the mind disease where the capacity recall and to think diminish along. These brain diseases affect capacity and a person’s rituals to execute. The changes is unnoticeable and small, but becomes severe. The case arises when diseases like strokes or Alzheimers impact the mind. Even though Alzheimers has been counted as the most important reason behind dementia, other potential cases to remain.
Wound healing gets slow in diabetic patients due to a number of factors such as High blood sugar levels (When your blood sugar level is higher than normal, it prevents nutrients and oxygen from energizing cells which prevents your immune system from functioning efficiently and eventually increases inflammation in the body’s cells.
Along with prevention and treatment, management is very important and plays a crucial role in diabetes. . Management of diabetes mainly aims to minimize the risk of long-term consequences associated with diabetes. It not only involves keeping a check on blood sugar, blood pressure and cholesterol levels but also focusing on modern approaches like exercise, dietary and lifestyle management often coupled with on-going blood glucose level monitoring. Besides this, self-management of diabetes is also very crucial for the proper adherence to dietary and lifestyle modifications.
Untreated mental state problems can make diabetes worse, and issues with diabetes will build mental state problems worse. however if one starts recovering, the other will start recovering too. The main set of mental health problems in Diabetes includes-
The concept of 'new technologies' for type 1 diabetes and new discovery and advanced type 2 diabetes treatment has expanded in recent years at a rate that some might consider comparable to 'Moore’s Law', and the sheer number of new technologies entering into the type 1 diabetes marketplace is also growing at a remarkable rate. From the patient’s perspective, this is not only exciting but can lead to a sense of optimism. Technologies that today are growing commonplace. come under new therapeutic mechanisms of diabetes. Indeed, it could be argued that the major advances in type 1 diabetes care made within the last quarter of a century have come from technology rather than biology.
As per the studies conducted recently, there are more than twenty-seven million diabetes patients within the U.S.A., thus world’s third largest country in terms of diabetes patients in 2018. The major reasons behind these prevailing cases of diabetes is the rise of obesity levels associated with the increasing aging population. It's been found in the studies conducted that over half the U.S.A. population is either obese or overweight that is especially because of their inactive lifestyles, physical inactivities and unhealthy consumption habits. Moreover, the aging population within the U.S.A. has been on the increase since the 1960’s. individuals aged sixty five years and on top of accounted for around 11th of September of the overall population in 1960 whereas in 2018, this cohort accounted for around 15 August 1945 of the whole U.S.A. population. Driven by rising incidences of polygenic disorder and therefore the incontrovertible fact that the U.S.A. has one amongst the very best per capita tending expenditures, the U.S.A. marketplace for polygenic disorder medication has grownup at a CAGR of around eleven.8% throughout 2011-2018, reaching a price of US$ forty five.4 Billion in 2018.
Diabetes has increasingly become a lifestyle related disease as it afflicts young and old. As the number of patients grow across the globe, there has never been a stronger and more urgent need for novel therapeutic measures in clinical and preclinical evaluation, that arrest the growth of the disease. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes is large and growing significantly. Global diabetes market is expected to grow at CAGR of 7.6% for the forecasted period of 2018-2023.the market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 8.9% . some of the top selling diabetic drugs include Lantus(sanofi), Januvia(Merck and Co), Humalog(Eli Lily And Co),Novo rapid(Novo Nordisk),Levemir(Novo Nordisk),Victoza(Novo Nordisk),Janumet(Merck And Co),Novolog(Novo Nordisk),Humalin (Eli Lily And Co) and Galvus (Novartis).with the diabetic population expected to cross the 350 million market by 2030 the market is expected to show strong growth rate. Diabetic drugs are highly priced which could be one of the major drawbacks.
Diabetes drug research market in Europe is expected to progress with a 5.08% CAGR over the forecast years of 2018-2026. It is the second largest market for diabetes drugs. High blood glucose kills about 3.4 million people annually worldwide. Approximately 80% of these deaths take place in underdeveloped and developing countries, and almost half are people aged less than 70 years. As per recent research in WHO diabetic deaths will double between 2005 and 2030. India had 69.2 million people living with diabetes (8.7%) in 2015. About 90% of the patients are suffering from Type 2 diabetes. Diabetes Research Market is expected to grow at the average CAGR of 6.5% time period of 2016-2023. India’s Diabetes Market is growing rapidly. India is expected to grow US$ 7441.6 million by 2023 from US$ 4778.7 million in 2016. The data varies from $263 billion spent in North America to $147 billion in Europe and Northern Asia. Followed by China, Mongolia, South East Asia and Oceania with a total of $88 billion.
Societies Associated with Diabetes Research:
- SBDR - Society for Biomedical Diabetes Research
- Austrian Diabetes Association
- Flemish Diabetes Association
- Association of Juvenile Diabetes
- Canadian Diabetes Association
- Juvenile Diabetes Foundation of Chile
- German Diabetes Union
- Diabetic Society of Singapore
- Japan Diabetes Society
- Hong Kong Diabetes Federation
- The International Society of Gynecological Endocrinology
- Royal Society of Medicine Endocrinology and Diabetes Section
- International Society of Psych neuroendocrinology
- International Neuroendocrine Federation
- European Society of Endocrinology
- Clinical Endocrinology Trust
- Swiss Diabetes Society
- Spanish Diabetes Society
- Korean Diabetes Association
Diabetic Research Centers World wide:
- University of Michigan Albert Einstein-Mount Sinai Diabetes Center
- Boston Area
- Columbia University
- Indiana University
- Johns Hopkins University/University of Maryland
- Joslin Diabetes Center - Harvard Medical School
- Stanford University
- University of Alabama at Birmingham
- University of Chicago
- University of Michigan
- University of Pennsylvania
- University of Washington
- Washington University
- Vanderbilt University
- Yale University
- Albert Einstein College of Medicine
- Emory University
- Kaiser Foundation Research Institute
- University of Chicago
- University of Colorado
- International Diabetes Federation, UAE
- Public Health Research Center, Abu Dhabi, UAE
- Imperial College London Diabetes Centre, UAE
- Global Diabetes Research Centre, India.
- Diabetes Research Center, PUMCH, China
- Center for Diabetes & Endocrinology, Japan
- Leicester Diabetes Centre, United Kingdom
- Garvan Institute of Medical Research, Australia
- Persatuan Diabetes Indonesia Research Centre
- Mayo Clinic – Rochester, MN
- Cleveland Clinic – Cleveland, OH
- Massachusetts General Hospital – Boston, MA
- Johns Hopkins Hospital – Baltimore, MD
- UCSF Medical Center – San Francisco, CA
- New York-Presbyterian University Hospital of Columbia and Cornell – New York, NY
- Yale-New Haven Hospital – New Haven, CT
- Northwestern Memorial Hospital – Chicago, IL
- UCLA Medical Center – Los Angeles, CA
- University of Washington Medical Center – Seattle, WA
- Hospitals of the University of Pennsylvania-Penn Presbyterian – Philadelphia, PA
- Brigham and Women’s Hospital – Boston, MA
- Florida Hospital Orlando – Orlando, FL
- Cedars-Sinai Medical Center – Los Angeles, CA
- Barnes-Jewish Hospital/Washington University – St. Louis, MO
- Beaumont Hospital – Grosse Pointe, MI
- Mount Sinai Hospital – New York, NY
- Froedtert Hospital and the Medical College of Wisconsin – Milwaukee, WI
- Lancaster General Hospital – Lancaster, PA
- University of Kansas Hospital – Kansas City, KS
- KEM Hospital, Pune
- Lakeshore Hospital & Research Center, Kochi
- All India Institute of Medical Sciences (AIIMS), Delhi
- M.V. Hospital for Diabetes, Chennai
- St Vincent's Hospital Sydney
- The Australian Centre for Behavioral Research in Diabetes.
- Mahkota Diabetes Centre, Indonesia
- Newcastle Hospitals, UK
- Parkmore Medical Centre, South Africa
- Degla Diabetic Center, Egypt
- Diabetes & Metabolism Centre, Singapore
Previous Conference Report
Euroscicon conference “3rd World Congress on Diabetes and Obesity” formally Diabetes Conference 2019 was held in Holiday innRome Aurelia | Rome, Italy during 18-19 March, 2019 with active participation of professional researchers, scientists involved in the development of high-quality education & research in all aspects.
Diabetes Conference 2019 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various topics related to the field of Diabetes and Obesity. The highly exalted conference hosted by EuroSciCon was marked with the attendance of renowned and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to the theme “Recent advances in Diabetes and Obesity”.
We are thankful to all our attendees for encouraging and supporting us in successful conduct of the conference.
In person, we would like to express our sincere thanks to our moderator Dr. Pablo Balino, Jaume I University, Spain for his tremendous support to embark a magnificent start to the conference. His continued support marked a smooth conduct to run through the program ending in a successive conclusion.
Next we would like to thank our Organizing committee member cum keynote speaker Dr. Shota Janjgava, National Institute of Endocrinology, Tbilisi, Georgia for his valuable contribution towards the conference.
He was also the poster judge for the conference.
Further we would like to extend our thanks to Dr. Angelo Michele Carella, "T. Masselli-Mascia" Hospital, San Severo (Foggia) - Italy for his continued support as a chair and OCM to the conference.
After the successful conduct of “3rd World Congress on Diabetes and Obesity” in Rome, Italy during 18-19 March, 2019. We take the immense pleasure to announce the next edition of our congress in Dublin, Ireland. This time we have planned to organize a better and bigger congress that will include various aspects of researches that left unfocussed in our last edition.
Let us meet again @Dublin
We always try to provide the best possible help to our attendees in order to obtain their visa.
A personalized invitation letter is provided to the registered attendees on request.
Mail us after your registration to obtain the personalized Invitation letter